Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 24/04/19961 min de lecture
Personal Blood Storage of Memphis, Inc.; Opportunity for Hearing on a Proposal to Revoke U.S. License No. 1131
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing an opportunity for a hearing on a proposal to revoke the establishment license (U.S. License No. 1131) and the product licenses issued to Personal Blood Storage of Memphis, Inc., for the manufacture of Whole Blood, Red Blood Cells, Plasma, and Platelets. The proposed revocation is based on the establishment's discontinuing of manufacturing of products to the extent that a meaningful inspection or evaluation cannot be made.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →